[18F]Fluoro-L-DOPA PET/CT in congenital hyperinsulinism

Journal of Computer Assisted Tomography

Volumn 31, Issue 5, 2007, Pages 770-772

  Subramaniam, Rathan M ^a   Karantanis, Dimitrios ^a   Peller, Patrick J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Congenital hyperinsulinism; F DOPA PET CT

Indexed keywords

CONGENITAL HYPERINSULINISM; F-DOPA PET/CT; INSULIN SECRETION; LEVODOPA; NON-INVASIVE IMAGING; POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHIES;

CORTICOTROPIN; DIAZOXIDE; GLUCAGON; GROWTH HORMONE; HYDROCHLOROTHIAZIDE; HYDROCORTISONE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; LEVODOPA F 18; TRACER; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; DOPA; DRUG DERIVATIVE; FLUORINE; FLUORODOPA F 18; RADIOPHARMACEUTICAL AGENT;

ADD ON THERAPY; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; ECHOGRAPHY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HYPOGLYCEMIA; INBORN ERROR OF METABOLISM; INFANT; PANCREAS RESECTION; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; DIFFERENTIAL DIAGNOSIS; RADIOGRAPHY; SCINTISCANNING;

DIAGNOSIS, DIFFERENTIAL; DIHYDROXYPHENYLALANINE; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; INFANT; PERSISTENT HYPERINSULINEMIA HYPOGLYCEMIA OF INFANCY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34748824208     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e318031f55c     Document Type: Article

References (25)

1. Stanley C. Hyperinsulinism in infants and children. Pediatr Clin North Am. 1997;44:363-374.
2. Bruining G. Recent advances in hyperinsulinism and the pathogenesis of diabetes mellitus. Curr Opin Pediatr. 1990;2:758-765.
3. Thomas C, Underwood L, Carney C, et al. Neonatal and infantile hypoglycemia due to insulin excess: new aspects of diagnosis and surgical management. Ann Surg. 1977;185:505-517.
4. Rahier J, Falt K, Muntefering H, et al. The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: deficiency of pancreatic D cells or hyperactivity of B cells? Diabetologia. 1984;26:282-289.
5. Goossens A, Gepts W, Saudubray J, et al. Diffuse and focal nesidioblastosis: a clinicopathological study of 24 patients with persistent neonatal hyperinsulinemic hypoglycemia. Am J Surg Pathol. 1989;13:766-775.
6. de Lonlay-Debeney P, Poggi-Travert F, Fournet J-C, et al. Clinical features of 52 neonates with hyperinsulinism. N Engl J Med. 1999;340:1169-1175.
7. Thomas P, Cote G, Wohllk N, et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science. 1995;268:426-429.
8. Fournet J, Mayaud C, de Lonlay P, et al. Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozygosity of a mutation in ABCC8 or KCNJ1 1. Am J Pathol. 2001;158:2177-2184.
9. Shilyanski J, Fisher S, Cutz E, et al. Is 95% pancreatectomy the procedure of choice for treatment of persistent hyperinsulinemic hypoglycemia of the neonate? J Pediatr Surg. 1997;32:342-346.
10. Leibowitz G, Glaser B, Higazi A, et al. Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: high incidence of diabetes mellitus and persistent β-cell dysfunction at long-term follow-up. J Clin Endocrinol Metab. 1995;80:386-392.
11. Labrune P, Lechevallier S, Rault M, et al. Diabetes mellitus 14 years after subtotal pancreatectomy for neonatal hyperinsulinism. J Pediatr Surg. 1990;25:1246-1247.
12. Lyonnet S, Bonnefont J, Saudubray J, et al. Localisation of focal lesion permitting partial pancreatectomy in infants. Lancet. 1989;2:671.
13. Dubois J, Brunelle F, Touati G, et al. Hyperinsulinism in children: diagnostic value of pancreatic venous sampling correlated with clinical, pathological and surgical outcome in 25 cases. Pediatr Radiol. 1995;25:512-516.
14. Chigot V, De Lonlay P, Nassogne M, et al. Pancreatic arterial calcium stimulation in the diagnosis and localisation of persistent hyperinsulinemic hypoglycaemia of infancy. Pediatr Radiol. 2001;31(9):650-655.
15. Lemmer K, Ahnert-Hilger G, Hopfner M, et al. Expression of dopamine receptors and transporter in neuroendocrine gastrointestinal tumor cells. Life Sci. 2002;71:667-678.
16. Rodriguez M, Saura J, Finch C, et al. Localization of monoamineoxidase A and B in human pancreas, thyroid and adrenal glands. J Histochem Cytochem. 2000;48:147-151.
17. Orlefors H, Sundin A, Fasth K, et al. Demonstration of high monoaminoxidase-A levels in neuroendocrine gastroenteropancreatic tumors in vitro and in vivo: tumor visualization using positron emission tomography with 11 C-harmine. Nucl Med Biol. 2003;30:669-679.
18. Borelli M, Villar M, Orezzoli A, et al. Presence of DOPA decarboxylase and its localisation in adult rat pancreatic islet cells. Diabetes Metab. 1997;23:161-163.
19. 18F]-DOPA positron emission tomography. Diabetes. 2006;55:13-18.
20. 18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion. J Clin Endocrinol Metab. 2006;91:933-940.
21. 18F-fluoro-l-DOPA. J Nucl Med. 2005;46:560-566.
22. Lindstrom P. Aromatic-L-amino-acid decarboxylase activity in mouse pancreatic islets. Biochim Biophys Acta. 1986;884:276-281.
23. Borelli M, Villar M, Orezzoli A, et al. Presence of DOPA decarboxylase and its localisation in adult rat pancreatic islet cells. Diabetes. 1997;23:161-163.
24. Geng X, Li L, Watkins S, et al. The insulin secretory granule is the major site of K(ATP) channels of the endocrine pancreas. Diabetes. 2003;52:767-776.
25. Labrune P, Lechevallier S, Rault M, et al. Diabetes mellitus 14 years after subtotal pancreatectomy for neonatal hyperinsulinism. J Pediatr Surg. 1990;25:1246-1247.